Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Rickey Carter and DeLisa Fairweather.
Rickey Carter
Connection Strength
0.812
DeLisa Fairweather
  1. In Reply-How Safe Is COVID-19 Convalescent Plasma? Mayo Clin Proc. 2021 08; 96(8):2281-2282.
    View in: PubMed
    Score: 0.238
  2. In Reply - Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients. Mayo Clin Proc. 2020 12; 95(12):2802-2803.
    View in: PubMed
    Score: 0.226
  3. Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors. Nat Commun. 2021 08 11; 12(1):4864.
    View in: PubMed
    Score: 0.060
  4. Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence. Front Med (Lausanne). 2021; 8:684151.
    View in: PubMed
    Score: 0.059
  5. The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis. Mayo Clin Proc. 2021 05; 96(5):1262-1275.
    View in: PubMed
    Score: 0.058
  6. Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19. N Engl J Med. 2021 03 18; 384(11):1015-1027.
    View in: PubMed
    Score: 0.058
  7. Early safety indicators of COVID-19 convalescent plasma in 5000 patients. J Clin Invest. 2020 09 01; 130(9):4791-4797.
    View in: PubMed
    Score: 0.056
  8. Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients. Mayo Clin Proc. 2020 09; 95(9):1888-1897.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.